Paper21148331
RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis.
Schnittger S and 7 others. Blood, 2011. Cited by 209 papers, by iCite.
Cite this record
ConductScience Library. RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis. Papers, record 21148331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21148331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Core Binding Factor Alpha 2 Subunit | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Mutation | Major topic |
| fms-Like Tyrosine Kinase 3 | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Cytogenetic Analysis | |
| Humans | |
| Inverted Repeat Sequences | |
| Kaplan-Meier Estimate | |
| Karyotyping | |
| Leukocyte Count | |
| Middle Aged | |
| Prognosis | |
| Survival Rate | |
| Young Adult |
Source PubMed
Cited by119
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 209 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42706154 | [Clinical characteristics and prognosis of acute myeloid leukemia patients with RUNX1 single-site and multiple-site gene mutations]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | https://conductscience.org/library/papers/42706154 | PubMed |
| 41924923 | Preemptive hematopoietic stem cell transplantation in RUNX1 familial platelet disorder: a shared decision-making framework. | Haematologica | 2026 | https://conductscience.org/library/papers/41924923 | PubMed |
| 41430607 | The METTL3-YTHDC1 axis mediates architectural RNA m6A modification to modulate the integrity of chromatin TADs in MLLr + AML genome. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41430607 | PubMed |
| 41388195 | A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia. | Leukemia | 2026 | https://conductscience.org/library/papers/41388195 | PubMed |
| 40763310 | CBFβ-SMMHC-driven leukemogenesis requires enhanced RUNX1-DNA binding affinity in mice. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40763310 | PubMed |
| 40558237 | Clinical Effects of RUNX1 Mutations on the Outcomes of Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem-Cell Transplantation. | Curr Oncol | 2025 | https://conductscience.org/library/papers/40558237 | PubMed |
| 39822584 | Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy). | Hemasphere | 2025 | https://conductscience.org/library/papers/39822584 | PubMed |
| 39450904 | JMJD1C forms condensate to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells. | Protein Cell | 2025 | https://conductscience.org/library/papers/39450904 | PubMed |
| 39367609 | Advancements in genetic analysis: Insights from a case study and review of next-generation sequencing techniques for veterinary oncology applications. | Vet Clin Pathol | 2025 | https://conductscience.org/library/papers/39367609 | PubMed |
| 38316746 | Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM). | Blood Cancer J | 2024 | https://conductscience.org/library/papers/38316746 | PubMed |
| 37188777 | RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group. | Leukemia | 2023 | https://conductscience.org/library/papers/37188777 | PubMed |
| 36788336 | Control of focal adhesion kinase activation by RUNX1-regulated miRNAs in high-risk AML. | Leukemia | 2023 | https://conductscience.org/library/papers/36788336 | PubMed |
| 36544784 | Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia. | Front Immunol | 2022 | https://conductscience.org/library/papers/36544784 | PubMed |
| 36463299 | Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain. | Epigenetics Chromatin | 2022 | https://conductscience.org/library/papers/36463299 | PubMed |
| 36358658 | Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358658 | PubMed |
| 36232714 | RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232714 | PubMed |
| 36077669 | Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077669 | PubMed |
| 35884618 | NF-κB: A Druggable Target in Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35884618 | PubMed |
| 35884612 | Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35884612 | PubMed |
| 35384048 | Prediction of survival with intensive chemotherapy in acute myeloid leukemia. | Am J Hematol | 2022 | https://conductscience.org/library/papers/35384048 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FLT3 | 2322 | PubTator's text mining | https://conductscience.org/library/genes/2322 | NCBI Gene |
| KMT2A | 4297 | PubTator's text mining | https://conductscience.org/library/genes/4297 | NCBI Gene |
| NRAS | 4893 | PubTator's text mining | https://conductscience.org/library/genes/4893 | NCBI Gene |
| RUNX1 | 861 | PubTator's text mining | https://conductscience.org/library/genes/861 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21148331
GET https://conductscience.org/api/papers/v1/21148331/cited_by?page=2